Teva UK introduces first generic oral anticoagulant
Apixaban will be available for the prevention of stroke and deep vein thrombosis
Read More
Tag: generics
Mallinckrodt to split business
UK-based specialty pharma group Mallinckrodt has unveiled plans to spin-off its specialty generics and active pharmaceutical ingredients business into a new company
Read More
Sanofi to sell generics unit for 1.9 billion Euros
Global investment group Advent International says it has entered into exclusive negotiations to buy Sanofi’s generics arm Zentiva for 1.9 billion Euros ($2.4 billion).
Read More
Teva buys Allergan’s drug distribution group
Teva Pharmaceutical Industries has unveiled plans to buy Allergan-owned US generics giant Anda for $500 million.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
